Investments in and Advances to Joint Ventures (Tables)

3 Months Ended

Mar. 31, 2021

Equity Method Investments And Joint Ventures [Abstract]

Schedule of Financial Information of Consolidated Joint Ventures

The following represents financial information for consolidated joint ventures included in the consolidated financial statements (in thousands):

	March 31, 2021		December 31, 2020
Current assets	$	299,764	$	292,407
Noncurrent assets		2,888		2,990
Total assets		302,652		295,397
Current liabilities		214,015		201,270
Total liabilities		214,015		201,270
Total joint venture equity	$	88,637	$	94,127

	Three Months Ended
	March 31, 2021		March 31, 2020
Revenue	$	96,624	$	100,278
Costs		86,306		97,150
Net income	$	10,318	$	3,128
Net income attributable to noncontrolling interests	$	4,975	$	1,398

Summary of Financial Information for Unconsolidated Joint Ventures

The following represents the financial information of the Company’s unconsolidated joint ventures as presented in their unaudited financial statements (in thousands):

	March 31, 2021		December 31, 2020
Current assets	$	740,595	$	774,646
Noncurrent assets		580,224		585,802
Total assets		1,320,819		1,360,448
Current liabilities		673,872		703,287
Noncurrent liabilities		528,168		517,697
Total liabilities		1,202,040		1,220,984
Total joint venture equity	$	118,779	$	139,464
Investments in and advances to unconsolidated joint ventures	$	76,017	$	68,975

	Three Months Ended
	March 31, 2021		March 31, 2020
Revenue	$	236,517	$	238,188
Costs		210,847		223,686
Net income	$	25,670	$	14,502
Equity in earnings of unconsolidated joint ventures	$	7,530	$	6,114